Phone: 855-387-6724 | Fax: 855-616-2776

Business Associate Agreement

THIS BUSINESS ASSOCIATE AGREEMENT (this “Agreement”) is entered into as of the date of submission of the Patient Enrollment Form (the “Effective Date”), by and between the currently logged in business (“Covered Entity”) and Copilot Provider Support Services (“Business Associate”) with an address of 1981 Marcus Avenue, New Hyde Park, NY 11042. RECITALS WHEREAS, Business Associate performs services (“Services”) on behalf of Covered Entity pursuant one or more underlying agreements (each, an “Underlying Agreement(s)”), which Services involve the Use and/or Disclosure of Protected Health Information (defined below); and WHEREAS, the parties desire to enter into this Agreement in order to comply with the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) and its implementing regulations, as amended and in effect. NOW, THEREFORE, the parties do hereby agree as follows: 1. Definitions. Capitalized terms not otherwise defined in this Agreement shall have the same meaning as those terms in the Privacy Rule and the Security Rule (defined below). a) “Breach” when capitalized, “Breach” shall have the meaning set forth in 45 CFR § 164.402 (including all of its subsections); with respect to all other uses of the word “breach” in this Agreement, the word shall have its ordinary contract meaning. b) “Electronic Protected Health Information” or “EPHI” shall have the same meaning as the term “electronic protected health information” in 45 CFR § 160.103, limited to information that Business Associate creates, accesses or receives on behalf of Covered Entity. c) “Protected Health Information” or “PHI” shall have the meaning set forth in the Privacy Rule, limited to information that Business Associate creates, accesses or receives on behalf of Covered Entity. PHI includes EPHI. d) “Privacy Rule” means the Standards for Privacy of Individually Identifiable Health Information, codified at 45 CFR parts 160 and 164, Subparts A, D, and E, as currently in effect. e) “Security Rule” means the Standards for Security for the Protection of Electronic Protected Health Information, codified at 45 CFR parts 160 and 164, Subpart C. f) “Unsecured Protected Health Information” shall have the same meaning as the term “unsecured protected health information” in 45 CFR § 164.402, limited to the information created or received by Business Associate from or on behalf of Covered Entity. 2. Business Associate Obligations. Business Associate acknowledges and agrees that it is considered a “Business Associate” as defined by HIPAA. As a Business Associate of Covered Entity, Business Associate shall, in addition to complying with the terms of this Agreement, comply with the following and any state provisions that are more restrictive: a) Uses and Disclosures. Business Associate shall not Use or further Disclose PHI other than as permitted or required by this Agreement, to perform Services under the Underlying Agreement or as Required By Law, provided that: i) Such Use or Disclosure would not violate HIPAA if done by Covered Entity; and ii) Such Use or Disclosure shall be limited to the minimum necessary to accomplish the permissible purpose(s) of the Use or Disclosure. b) Uses and Disclosures Permitted By Law. As permitted by the Privacy Rule, Business Associate may Use or Disclose PHI: (a) as is necessary for the proper management and administration of Business Associate’s organization, (b) to provide data aggregation services relating to the health care services of the Covered Entity; and (c) to carry out the legal responsibilities of Business Associate; provided, however, that any permitted Disclosure of PHI to a third party must be either Required By Law or subject to reasonable assurances obtained by Business Associate from the third party that PHI will be held confidentially, and securely, and Used or Disclosed only as Required By Law or for the purposes for which it was disclosed to such third party, and that any breaches of confidentiality of PHI which become known to such third party will be immediately reported to Business Associate. c) Privacy Rule. To the extent Business Associate carries out one or more of Covered Entity’s obligations under the Privacy Rule, Business Associate shall comply with the requirements of HIPAA that apply to Covered Entity in the performance of such obligation(s). d) Safeguards. Business Associate shall use safeguards that are appropriate and sufficient to prevent Use or Disclosure of PHI other than the Uses and Disclosures permitted or required by this Agreement. Business Associate shall comply with the Security Rule with respect to EPHI, including implementing Administrative Safeguards, Physical Safeguards, and Technical Safeguards that reasonably and appropriately protect the Confidentiality, Integrity and Availability of EPHI. e) Reporting. Business Associate shall report to Covered Entity any Use or Disclosure of PHI not permitted or required by this Agreement and any Security Incident of which it becomes aware. f) Agents and Subcontractors. Business Associate shall ensure that any and all subcontractors that create, receive, maintain or transmit PHI on behalf of Business Associate agree, in writing prior to the subcontractors’ receipt of such PHI, to the same terms and conditions of this Agreement with respect to PHI. Each subcontract agreement must contain the same restrictions and conditions that apply to Business Associate with respect to PHI, including without limitation the provisions of this Agreement. Business Associate shall make such agreements with its subcontractors available to Covered Entity upon Covered Entity’s request. g) Patient Rights. i) Patient Right to Access. Business Associate shall make PHI in a Designated Records Set that it maintains available to Covered Entity within ten (10) days or, as directed by Covered Entity, to the subject of the PHI, in compliance with the requirements of 45 C.F.R. §164.524. If any Individual requests access to his or her own PHI from Business Associate, Business Associate shall, within two (2) business days, notify Covered Entity of the details of such request. ii) Patient Right to Amend. Business Associate shall incorporate amendment(s) to PHI in a Designated Records Set that it maintains within ten (10) days of receipt of Covered Entity’s request and in compliance with 45 C.F.R. §164.526. If any Individual submits to Business Associate a request to amend his or her own PHI, Business Associate shall, within two (2) business days, notify Covered Entity of the details of such request. iii) Patient Right to Request Accounting. Business Associate shall document and make available to Covered Entity the information required to provide an accounting of disclosures within ten (10) days of receipt of Covered Entity’s request or, as directed by Covered Entity, to the subject of the PHI, in compliance with the requirements of 45 C.F.R. §164.528. If any Individual requests an accounting from Business Associate, Business Associate shall, within two (2) business days, notify Covered Entity of the details of such request. (1) Business Associate agrees to implement an appropriate record keeping process to enable it to comply with the requirements of this Section. (2) Business Associate agrees to provide PHI it maintains electronically in a Designated Record Set in an electronic form at the request of Covered Entity or an Individual. h) Audit. Business Associate shall make its internal practices, books, and records relating to the Use and Disclosure of PHI received from, or created or received by Business Associate on behalf of Covered Entity available to the Secretary of Health and Human Services, upon request, for purposes of determining and facilitating Covered Entity’s compliance with HIPAA. i) Mitigation. Business Associate shall mitigate promptly, to the extent practicable, any harmful effect that is known to Business Associate of a Use or Disclosure of PHI by Business Associate in violation of this Agreement, the Privacy Rule, the Security Rule, or other applicable federal or state law. j) Breach. If Business Associate has knowledge or a reasonable belief that a Breach or potential Breach of Unsecured Protected Health Information has occurred or may have occurred, Business Associate shall promptly (no later than five (5) days after it has knowledge that a Breach or reasonable belief that a Breach has or may have occurred) notify the Covered Entity in accordance with the requirements of 45 CFR § 164.410. Such notification shall include, to the extent possible, the identification of each Individual whose PHI has been or is reasonably believed to have been accessed, acquired, Used or Disclosed during the Breach, along with any other information that the Covered Entity will be required to include in its notification to the Individual, the media and/or the Secretary, as applicable, including, without limitation, a description of the Breach, the date of the Breach and its discovery, the types of Unsecured Protected Health Information involved and a description of the Business Associate’s investigation, mitigation, and prevention efforts. 3. Covered Entity Obligations. a) Notice of Privacy Practices. Covered Entity shall notify Business Associate of limitation(s) in its notice of privacy practices, to the extent such limitation affects Business Associate’s permitted Uses or Disclosures. b) Individual Permission. Covered Entity shall notify Business Associate of changes in, or revocation of, permission by an Individual to Use or Disclose PHI, to the extent such changes affects Business Associate’s permitted Uses or Disclosures. c) Restrictions. Covered Entity shall notify Business Associate of restriction(s) in the Use or Disclosure of PHI that Covered Entity has agreed to, to the extent such restriction affects Business Associate’s permitted Uses or Disclosures. 4. Term & Termination. a) Term. The Term of this Agreement shall begin on the Effective Date, and shall terminate when all PHI provided by Covered Entity to Business Associate is destroyed or returned to Covered Entity, or if it is infeasible to return or destroy all PHI, protections are extended to such information in accordance with the termination provisions in this Section. b) Termination. i) By Covered Entity. Upon Covered Entity’s knowledge of a material breach by Business Associate of this Agreement, Covered Entity shall: (1) Terminate this Agreement and the Underlying Agreement upon thirty (30) days’ notice if Covered Entity determines that Business Associate has violated a material term of this Agreement if, following Covered Entity’s notification to Business Associate of the material breach, Business Associate is unable or unwilling to take steps to cure the breach within such thirty (30) day period. In the event of such a cure, this Agreement shall remain in full force and effect; or (2) Immediately terminate this Agreement and the Underlying Agreement if Business Associate has breached a material term of this Agreement and cure is not possible. ii) By Business Associate. Upon Business Associate’s knowledge of a material breach by Covered Entity of this Agreement, Business Associate shall: (1) Terminate this Agreement and the Underlying Agreement upon thirty (30) days’ notice if Business Associate determines that Covered Entity has violated a material term of this Agreement if, following Business Associate’s notification to Covered Entity of the material breach, Covered Entity is unable or unwilling to take steps to cure the breach within such thirty (30) day period. In the event of such a cure, this Agreement shall remain in full force and effect; or (2) Immediately terminate this Agreement and the Underlying Agreement if Covered Entity has breached a material term of this Agreement and cure is not possible. c) Return on Termination. At termination of the Agreement, to the extent feasible, Business Associate shall return or destroy all PHI that Business Associate still maintains in any form and retain no copies of PHI. If the return or destruction of such PHI is not feasible, Business Associate shall extend the protections of this Agreement to the remaining information and limit further Uses and Disclosures of PHI to those purposes that make the return or destruction of PHI infeasible. d) Survival. The terms of this Section shall survive the termination or expiration of this Agreement. 5. Required Disclosure. If Business Associate is confronted with legal action to disclose any PHI, Business Associate shall promptly notify and assist Covered Entity in obtaining a protective order or other similar order, and shall thereafter disclose only the minimum amount of PHI that is required to be disclosed in order to comply with the legal action, whether or not a protective order or other order has been obtained. 6. Indemnification. Business Associate agrees to indemnify, defend, and hold harmless Covered Entity and its directors, officers, affiliates, employees, agents, and permitted successors from and against any and all claims, losses, liabilities, damages, costs, and expenses (including reasonable attorneys’ fees) arising out of or related to Business Associate’s breach of its obligations under this Agreement, including, but not limited to a Breach of Unsecured Protected Health Information by Business Associate. 7. Compliance with Laws. Business Associate shall comply with all applicable federal, state and local laws, rules and regulations, including, without limitation, the requirements of HIPAA. 8. Underlying Agreement. Except as specifically required to implement the purposes of this Agreement, and except to the extent inconsistent with this Agreement, all terms of the Underlying Agreement shall remain in full force and effect. In the event of a conflict between the terms of the Underlying Agreement and this Agreement, this Agreement shall control. 9. No Third-Party Beneficiaries. Nothing express or implied in this Agreement is intended to confer, nor shall anything herein confer, upon any person other than the Covered Entity, Business Associate and their respective successors or assigns, any rights, remedies, obligations or liabilities whatsoever. 10. Ownership. Covered Entity shall be and remain the sole and exclusive owner of its PHI. 11. Amendment. The parties shall amend this Agreement from time to time by mutual written agreement in order to keep this Agreement consistent with any changes made to the HIPAA laws or regulations in effect as of the Effective Date and with any new regulations promulgated under HIPAA. Covered Entity may terminate the Agreement in whole or in part if the parties are unable to agree to such changes by the compliance date for such new or revised HIPAA laws or regulations. 12. Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be an original, but all of which taken together shall constitute one and the same agreement.

Furoscix

Furoscix and Furoscix Direct are registered marks of scPharmaceuticals Inc.
All other trademarks are the property of their respective owners.
© 2024 scPharmaceuticals Inc. All rights reserved.
US-FUR-24-00032 02/24
This site is intended for US Healthcare Professionals only